|
Market Closed -
Nasdaq
16:30:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 4.140 USD | -3.94% |
|
+4.02% | -24.29% |
| 10-21 | Alert wrongly tagged to Bolt Biotherapeutics withdrawn | RE |
| 08-11 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Bolt Biotherapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 182.7 | 48.96 | 42.52 | 20.48 | 10.5 | 7.975 | - | - |
| Change | - | -73.2% | -13.15% | -51.84% | -48.75% | -24.01% | - | - |
| Enterprise Value (EV) | -3.524 | -97.32 | -39.45 | 20.48 | 10.5 | 7.975 | 7.975 | 7.975 |
| Change | - | -2,661.37% | 59.46% | 151.92% | -48.75% | -24.01% | 0% | 0% |
| P/E | -1.65x | -0.55x | -0.61x | -0.32x | -0.31x | -0.18x | -0.21x | -0.13x |
| PBR | 0.73x | 0.29x | 0.38x | - | - | - | - | - |
| PEG | - | 0x | 0x | 0.03x | 0x | -0x | 0x | -0x |
| Capitalization / Revenue | 145x | 8.55x | 5.4x | 2.66x | 1.36x | 39.9x | 2.28x | 1x |
| EV / Revenue | -0x | -0x | -0x | 0x | 0x | 39.9x | 2.28x | 1x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | -0x | -0x | -0.12x | -0.17x | -0.13x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -59.4 | -47.2 | -36.6 | -33 | -17.85 | -23.36 | -20.19 | -30.84 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1.26 | 5.729 | 7.876 | 7.69 | 7.695 | 0.2 | 3.5 | 8 |
| EBITDA | -83.1 | -79.08 | -65.12 | - | - | - | - | - |
| EBIT 1 | -92.79 | -90.32 | -76.2 | -73.05 | -36.11 | -65 | -47.5 | -60 |
| Net income 1 | -98.59 | -88.1 | -69.2 | -63.12 | -33.38 | -47.4 | -47.5 | -60 |
| Net Debt | -186.2 | -146.3 | -81.97 | - | - | - | - | - |
| Reference price 2 | 98.000 | 26.000 | 22.400 | 10.702 | 5.468 | 4.140 | 4.140 | 4.140 |
| Nbr of stocks (in thousands) | 1,864 | 1,883 | 1,898 | 1,914 | 1,919 | 1,926 | - | - |
| Announcement Date | 3/30/22 | 3/29/23 | 3/21/24 | 3/24/25 | 3/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18x | - | - | - | 7.98M | |
| 19.17x | 6.81x | 13.53x | 1.55% | 66.22B | |
| 30.52x | 8.19x | 25.9x | 0.05% | 55.2B | |
| 36.31x | 6.45x | 19.27x | 0.89% | 52.79B | |
| 35.25x | 3.42x | 14.76x | -.--% | 45.53B | |
| 50.87x | 5.89x | 32.33x | -.--% | 43.94B | |
| -20.15x | 197.1x | -21.43x | -.--% | 41.64B | |
| 29.51x | 8.36x | 21.63x | 0.36% | 34B | |
| 29.85x | 6.32x | 16.4x | -.--% | 25.84B | |
| 32.16x | 5.92x | 19.93x | -.--% | 23.51B | |
| Average | 24.33x | 27.61x | 15.81x | 0.32% | 38.87B | |
| Weighted average by Cap. | 26.77x | 26.89x | 15.88x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BOLT Stock
- Valuation Bolt Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
